Cargando…
IMPA2 Downregulation Enhances mTORC1 Activity and Restrains Autophagy Initiation in Metastatic Clear Cell Renal Cell Carcinoma
Although mTOR inhibitors have been approved as first-line therapy for treating metastatic clear cell renal cell carcinoma (ccRCC), the lack of useful markers reduces their therapeutic effectiveness. The objective of this study was to estimate if inositol monophosphatase 2 (IMPA2) downregulation refe...
Autores principales: | Kuei, Chia-Hao, Lin, Hui-Yu, Lee, Hsun-Hua, Lin, Che-Hsuan, Zheng, Jing-Quan, Chen, Kuan-Chou, Lin, Yuan-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230261/ https://www.ncbi.nlm.nih.gov/pubmed/32235551 http://dx.doi.org/10.3390/jcm9040956 |
Ejemplares similares
-
Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma
por: Lin, Yuh-Feng, et al.
Publicado: (2019) -
mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiency
por: Li, Hongwu, et al.
Publicado: (2016) -
The Gαh/phospholipase C-δ1 interaction promotes autophagosome degradation by activating the Akt/mTORC1 pathway in metastatic triple-negative breast cancer
por: Lin, Hui-Yu, et al.
Publicado: (2020) -
mTORC1 restrains adipocyte lipolysis to prevent systemic hyperlipidemia
por: Paolella, Lauren M., et al.
Publicado: (2019) -
Cucurbitacin E Induces Autophagy via Downregulating mTORC1 Signaling and Upregulating AMPK Activity
por: Zha, Qing-Bing, et al.
Publicado: (2015)